The Digestive Tumour Committee is made up of a multidisciplinary team of professionals in: pathological anatomy, molecular biology, general and digestive surgery, digestion, nursing, medical oncology, radiotherapy oncology, psychology, radiodiagnosis and radiophysics, and radiological protection.
The treatment of a digestive tumour will depend on its typology, extension, and evolution. Depending on each case, there are therapeutic options available for surgery, external or internal radiotherapy (brachytherapy), or systemic treatments (chemotherapy, hormone therapy, drugs against molecular targets, etc.), and/or combinations of these.
Digestive tumours
The digestive tumour committee deals with cancers related to the digestive system.
Most of these tumours start in polyps that appear in the mucosa of the colon or rectum.
A malignant tumour originating from the mucosal cells of the stomach is called stomach cancer or gastric cancer.
Oesophageal cancer is a malignant tumour derived from the mucosal cells of the oesophagus.
The cells that line the inside of the bile ducts can transform into malignant cells, causing a “cholangiocarcinoma”.
Liver cancer occurs when liver cells develop changes (mutations) in their DNA.
pancreatic cancer is a disease in which malignant (cancer) cells form in the tissues of the pancreas.
This is a malignant tumour that occurs in the walls of the gallbladder. The tumour cell usually originates from the innermost or mucosal layer of the gallbladder.
Services included in this committee
The Tumour Committees are regulated under established protocols and are made up of a multidisciplinary team of expert doctors from the main specialities depending on the type of tumour. The IVO’s digestive tumour committee is made up of multidisciplinary medical teams from the following specialities:
